Invokana 300 mg 30 tabletten
SKU
1004
Batch:
24E196/049
Haltbarkeitsdatum:
30-06-2026
Oral blood glucose lowering agent. Selectively inhibits the sodium/glucose cotransporter 2 (SGLT2) in the kidney. Weakly inhibits SGLT1 in the intestine.
Active ingredients: Each tablet contains canagliflozin hemihydrate, equivalent to 300 mg of canagliflozin.
Additional ingredients: Each tablet contains 117.78 mg of lactose, Microcrystalline cellulose, Hydroxypropyl cellulose, Croscarmellose sodium, Magnesium stearate, Poly(vinyl alcohol), Titanium dioxide (E171), Macrogol 3350, Talc
Merkblatt
Verwandte Artikel
